- Home
- TWO vs LENZ Comparison
TWO vs LENZ Comparison
Compare TWO & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWO
- LENZ
- Stock Information
- Founded
- TWO 2009
- LENZ 2019
- Country
- TWO United States
- LENZ United States
- Employees
- TWO N/A
- LENZ N/A
- Industry
- TWO Real Estate Investment Trusts
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- TWO Real Estate
- LENZ Health Care
- Exchange
- TWO Nasdaq
- LENZ Nasdaq
- Market Cap
- TWO 1.0B
- LENZ 1.2B
- IPO Year
- TWO 2009
- LENZ 2021
- Fundamental
- Price
- TWO $9.68
- LENZ $23.36
- Analyst Decision
- TWO Buy
- LENZ Strong Buy
- Analyst Count
- TWO 8
- LENZ 4
- Target Price
- TWO $12.43
- LENZ $56.25
- AVG Volume (30 Days)
- TWO 1.6M
- LENZ 1.3M
- Earning Date
- TWO 10-27-2025
- LENZ 11-05-2025
- Dividend Yield
- TWO 14.05%
- LENZ N/A
- EPS Growth
- TWO N/A
- LENZ N/A
- EPS
- TWO N/A
- LENZ N/A
- Revenue
- TWO $532,207,999.00
- LENZ $17,500,000.00
- Revenue This Year
- TWO N/A
- LENZ N/A
- Revenue Next Year
- TWO N/A
- LENZ $285.82
- P/E Ratio
- TWO N/A
- LENZ N/A
- Revenue Growth
- TWO 498.21
- LENZ N/A
- 52 Week Low
- TWO $9.30
- LENZ $16.54
- 52 Week High
- TWO $14.28
- LENZ $50.40
- Technical
- Relative Strength Index (RSI)
- TWO 47.73
- LENZ 26.54
- Support Level
- TWO $9.30
- LENZ $21.21
- Resistance Level
- TWO $9.77
- LENZ $32.00
- Average True Range (ATR)
- TWO 0.21
- LENZ 2.38
- MACD
- TWO 0.00
- LENZ -0.94
- Stochastic Oscillator
- TWO 56.15
- LENZ 16.03
About TWO Two Harbors Investment Corp
Two Harbors Investment Corp is a real estate investment trust focused on investing in, financing, and managing residential mortgage-backed securities, or RMBS; residential mortgage loans; mortgage servicing rights; and commercial real estate. The majority of the company's investment portfolio is split between agency RMBS purchased from government-sponsored enterprises and nonagency RMBS. Two Harbors derives nearly all of its revenue in the form of interest income collected from its investments. The majority of this income is generated by available-for-sale securities, while residential mortgage loans held for investment in securitization trusts also contribute a sizable amount.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.